US FDA seeks to revise biocompatibility evaluations for devices
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has proposed revisions to its memo on how medical device companies should use the international standard ISO-10993 to ascertain potential toxicity concerns with regard to their products when they come into direct or indirect contact with the human body.